Abstract
Cancers of the kidney account for approximately 1.5 % of all cancers and cancer deaths (with an incidence of 5–8 per 100,000 population in the UK and commoner in males). Three main types of renal cancer are distinguished: (1) Wilms tumor, (2) renal cell carcinoma (RCC) (adenocarcinoma), and (3) medullary and transitional cell cancers of the renal pelvis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis and the pathogenesis of Wilms tumor. Pediatr Pathol. 1990;10:1–36.
Breslow NE, Beckwith JB. Epidemiological features of Wilms’ tumor: results of the national Wilms’ tumor study. J Natl Cancer Inst. 1982;68:429–36.
Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P. Familial Wilms’ tumor: a descriptive study. Med Pediatr Oncol. 1996;27:398–403.
Breslow NE, et al. Renal failure in the Denys-Drash and Wilms’ tumor-aniridia syndromes. Cancer Res. 2000;60(15):4030–2.
Burkland CE, Juzek RH. Familial occurrence of carcinoma of the ureter. J Urol. 1966;96:697–701.
Clericuzio CL, Martin RA. Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia. Genet Med. 2009;11(3):220–2.
Clericuzio C, Hingorani M, Crolla JA, van Heyningen V, Verloes A. Clinical utility gene card for: WAGR syndrome. Eur J Hum Genet. 2011;19(4).
Cohen AJ, Li FP, Berg S, et al. Hereditary renal cell carcinoma associated with a chromosomal translocation. N Engl J Med. 1979;301:592–5.
Foulkes WD, Bahubeshi A, Hamel N, Pasini B, Asioli S, Baynam G, Choong CS, Charles A, Frieder RP, Dishop MK, Graf N, Ekim M, Bouron-Dal Soglio D, Arseneau J, Young RH, Sabbaghian N, Srivastava A, Tischkowitz MD, Priest JR. Extending the phenotypes associated with DICER1 mutations. Hum Mutat. 2011;32:1381–4.
Fraumeni JF, Thomas LB. Malignant bladder tumors in a man and his three sons. J Am Med Assoc. 1967;201:507–9.
Golka K, Selinski S, Lehmann ML, Blaszkewicz M, Marchan R, Ickstadt K, Schwender H, Bolt HM, Hengstler JG. Genetic variants in urinary bladder cancer: collective power of the “wimp SNPs”. Arch Toxicol. 2011;85(6):539–54.
Gul D, et al. Third case of WAGR syndrome with severe obesity and constitutional deletion of chromosome (11)(p12p14). Am J Med Genet. 2002;107(1):70–1.
Hartmann A, et al. Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res. 2002;62(23):6796–802.
Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wilkenheiser-Brokamp KA, Suarez BK, Whelan AJ, Williams G, Bracamontes D, Messinger Y, Goodfellow PJ. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009;325:965.
Huff V, Amos CI, Douglass EG, et al. Evidence for genetic heterogeneity in familial Wilms’ tumor. Cancer Res. 1997;57:1859–62.
Lim DH, Maher ER. Genomic imprinting syndromes and cancer. Adv Genet. 2010;70:145–75.
Lynch HT, Walzak MP, Fried R, et al. Familial factors in bladder cancer. J Urol. 1979;122:458–61.
Maher ER. Genetics of familial renal cancers. Nephron Exp Nephrol. 2010;118(1):e21–6.
Maher ER, Yates JRW, Ferguson-Smith MA. Statistical analysis of the two stage mutation model in von Hippel–Lindau disease and in sporadic cerebellar haeman-gioblastoma and renal cell carcinoma. J Med Genet. 1990;27:311–4.
McCullough DL, Lamma DL, McLaughlin AP, et al. Familial transitional cell carcinoma of the bladder. J Urol. 1975;113:629–35.
McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF. A population-based case–control study of renal cell carcinoma. J Natl Cancer Inst. 1984;72:275–84.
Muto R, et al. Prediction by FISH analysis of the occurrence of Wilms tumor in aniridia patients. Am J Med Genet. 2002;108(4):285–9.
Noguera-Irizarry WG, Hibshoosh H, Papadopoulos KP. Renal medullary carcinoma: case report and review of the literature. Am J Clin Oncol. 2003;26:489–92.
Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE. WT1 mutations contribute to abnormal genital system development and hereditary Wilms’ tumour. Nature. 1991;353:431–4.
Rahman N, Arbour L, Tonin P, et al. Evidence for a familial Wilms’ tumour gene (FWT1) on chromosome 17q12–q21. Nat Genet. 1996;13:461–3.
Rahman N, et al. Confirmation of FWT1 as a Wilms’ tumour susceptibility gene and phe-notypic characteristics of Wilms’ tumour attributable to FWT1. Hum Genet. 1998;103(5):547–56.
Rahman N, et al. Penetrance of mutations in the familial Wilms tumor gene FWT1. J Natl Cancer Inst. 2000;92(8):650–2.
Rapley EA, Crockford GP, Teare D, et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet. 2000;24:197–200.
Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F, Maher ER. Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst. 2008;100(17):1260–2.
Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006a;43(9):705–15.
Scott RH, Walker L, Olsen ØE, Levitt G, Kenney I, Maher E, Owens CM, Pritchard-Jones K, Craft A, Rahman N. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006b;91(12):995–9.
Steiner G, Schoenberg MP, Linn JF, Mao L, Sidransky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med. 1997;3:621–4.
Teh BT, McArdle J, Chan SP, et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine. 1997;76:21–9.
van Heyningen V, Hoovers JM, de Kraker J, Crolla JA. Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion. J Med Genet. 2007;44:787–90.
Woodward ER, et al. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes. J Med Genet. 2000;37(5):348–53.
Woodward ER, Ricketts C, Killick P, Gad S, Morris MR, Kavalier F, Hodgson SV, Giraud S, Bressac-de Paillerets B, Chapman C, Escudier B, Latif F, Richard S, Maher ER. Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. Clin Cancer Res. 2008;14(18):5925–30.
Woodward ER, Skytte AB, Cruger DG, Maher ER. Population-based survey of cancer risks in chromosome 3 translocation carriers. Genes Chromosomes Cancer. 2010;49(1):52–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Hodgson, S.V., Foulkes, W.D., Eng, C., Maher, E.R. (2014). Urinary System. In: A Practical Guide to Human Cancer Genetics. Springer, London. https://doi.org/10.1007/978-1-4471-2375-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2375-0_7
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2374-3
Online ISBN: 978-1-4471-2375-0
eBook Packages: MedicineMedicine (R0)